Moderna Inc. Stock Sheds 5.4%, Underperforms Peers
Dow Jones2026/09/30 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.
Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.
Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 30, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BICO completes integration of Cellenion into SCIENION, retires Cellenion brand
Japanese Yen draws support from hot Tokyo CPI as USD bulls await US NFP report
A global bond market sell-off sweeps across the world, pushing the dollar to a 17-month high; the euro becomes the hardest-hit currency.
On Friday, the US dollar hovered near a 17-month high and is set to rise for the third consecutive week.
Japan’s Katayama says will beef up efforts to promote version of doge review of subsidies, funds
Crypto prices
More
